Alejandro Trepp Carrasco, M.D.
Endocrinology, Diabetes & Metabolism Physician in Plantation, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Alejandro Trepp Carrasco, M.D. reported a CMS MIPS final score of 19.2/100 - below the 83.5 national average - and filed 1,310 Medicare Part D claims in 2023.
- 19.2/100
- MIPS score · -64 vs avg
- 1K
- Part D claims, 2023
- 31%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1144518085 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-LOW · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1144518085
- ENUM-MID 2011
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-LOW 19.2/100
- RX-MID 1,310
- BOOK-LIGHT 519 in Florida
- PHOTO-FINISH Yolanta Kruszynska · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Richard Bergstro…
Richard Bergstrom
18.9 MIPS pts
- Trepp Carrasco ·…
Trepp Carrasco · this provider
19.2 MIPS pts
- Yolanta Kruszyns…
Yolanta Kruszynska
19.2 MIPS pts
- Nelson Madrilejo…
Nelson Madrilejo
19.3 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Alejandro Trepp Carrasco, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
19 ≥ 3rd percentile 3% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Alejandro Trepp Carrasco, M.D. sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Alejandro Trepp Carrasco, M.D. writes more Part D claims than 33% of them and scores higher on MIPS quality than 3% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Alejandro Trepp Carrasco, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Alejandro Trepp Carrasco, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Alejandro Trepp Carrasco, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Florida
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers
Endocrinology, Diabetes & Metabolism Physician ranks #98 among Florida's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Florida provider total, by primary NUCC taxonomy. The highlighted bar is Endocrinology, Diabetes & Metabolism Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Alejandro Trepp Carrasco, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 19.2/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Endocrinology, Diabetes & Metabolism Physician US NPIs
19.2/100 MIPS final score - 64.3 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Endocrinology, Diabetes & Metabolism Physician. Quality dim: 0. Cost dim: 63.9.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1144518085 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/12/2011 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Alejandro Trepp Carrasco, M.D.'s current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1144518085 is the unique 10-digit identifier CMS uses to link Trepp Carrasco across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Alejandro Trepp Carrasco, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$262
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Alejandro Trepp Carrasco, M.D.. To verify Alejandro Trepp Carrasco, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
61% brand-name claims vs 31% generic, on 1,310 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,988
- Total Day Supply
- 89,548
- Brand vs Generic
- 61% brand / 31% generic
- Brand Drug Cost
- $841K
- Generic Drug Cost
- $17K
Patient Demographics
- Average Patient Age
- 73.4 years
- Avg HCC Risk Score
- 1.52
- Gender Split
- 49% female / 51% male
- Age Distribution
- <65: 21, 65-74: 104, 75-84: 76, 85+: 24
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Alejandro Trepp Carrasco, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Ozempic
Ozempic
130 claims
- Levothyroxine Sodium
Levothyroxine Sodium
97 claims
- Jardiance
Jardiance
85 claims
- Metformin Hcl
Metformin Hcl
70 claims
- Synthroid
Synthroid
55 claims
- Trulicity 51
Trulicity
51 claims
- Metformin Hcl Er 37
Metformin Hcl Er
37 claims
- Novolog Flexpen 37
Novolog Flexpen
37 claims
| Drug | Claims |
|---|---|
| Ozempic Semaglutide | 130 |
| Levothyroxine Sodium | 97 |
| Jardiance Empagliflozin | 85 |
| Metformin Hcl | 70 |
| Synthroid Levothyroxine Sodium | 55 |
| Trulicity Dulaglutide | 51 |
| Metformin Hcl Er Metformin Hcl | 37 |
| Novolog Flexpen Insulin Aspart | 37 |
| Rosuvastatin Calcium | 31 |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 29 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Endocrinology, Diabetes & Metabolism Physician Overview
How Alejandro Trepp Carrasco, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
Alejandro Trepp Carrasco, M.D.'s 1,310 claims are below the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Trepp Carrasco, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (19.2 here).
Same NPPES enumeration year (2011)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Trepp Carrasco.
One of 519 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Florida, 5 are shown here.
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Alejandro Trepp Carrasco, M.D.'s specialty? ▼
How much does Alejandro Trepp Carrasco, M.D. prescribe under Medicare Part D? ▼
What is Alejandro Trepp Carrasco, M.D.'s Medicare quality score? ▼
Where is Alejandro Trepp Carrasco, M.D. located? ▼
What is Alejandro Trepp Carrasco, M.D.'s NPI number? ▼
Does Alejandro Trepp Carrasco, M.D. prescribe more brand-name or generic drugs? ▼
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
What drugs does Alejandro Trepp Carrasco, M.D. prescribe most often? ▼
Does Alejandro Trepp Carrasco, M.D. accept Medicare? ▼
How can I verify Alejandro Trepp Carrasco, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.